Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection

Published:2021-08 Issue: Volume:905 Page:174191
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Khezri Mohammad Rafi^ORCID,Zolbanin Naime Majidi,Ghasemnejad-berenji Morteza,Jafari Reza^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference139 articles.

1. Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19?;Abouhashem;Antioxidants Redox Signal.,2020

2. Impact of azithromycin and/or hydroxychloroquine on hospital mortality in COVID-19;Albani;J. Clin. Med.,2020

3. Azithromycin for prevention of exacerbations of COPD;Albert;N. Engl. J. Med.,2011

4. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19;Arshad;Int. J. Infect. Dis.,2020

5. Targeting potential drivers of COVID-19: neutrophil extracellular traps;Barnes;J. Exp. Med.,2020

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occurrence of COVID-19 in cystic fibrosis patients: a review;Frontiers in Microbiology;2024-04-17

2. Regional and National Trends in Consumption of Antimicrobials in Pakistan; Pre and Post-COVID (2019–2021);Clinical Infectious Diseases;2023-12-15

3. Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana;Expert Review of Anti-infective Therapy;2023-11-20

4. Increased risk of chronic fatigue syndrome following infection: a 17-year population-based cohort study;Journal of Translational Medicine;2023-11-11

5. The pharmacological effects of Berberine and its therapeutic potential in different diseases: Role of the phosphatidylinositol 3‐kinase/AKT signaling pathway;Phytotherapy Research;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3